Page last updated: 2024-08-23

alpidem and Anxiety Neuroses

alpidem has been researched along with Anxiety Neuroses in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's8 (72.73)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Hanlon, JF; Swijgman, HF; Uiterwijk, MM; van Veggel, LM; Vermeeren, A1
Albizzati, MG; Bassi, S; Borghi, C; Frattola, L; Garreau, M; Morselli, PL; Piolti, R1
Barki, J; Gineston, JL; Lamblin, G; Larrey, D; Michel, H; Pageaux, G1
Garreau, M; Morselli, PL; Zivkovic, B1
Lader, M; Morton, S2
Albizzati, MG; Bassi, S; Borghi, C; Bottani, MS; Cesana, BM; Frattola, L; Morselli, PL; Piolti, R; Priore, P1
Morselli, PL1
Albizzati, MG; Bassi, S; Cesana, B; Farolfi, A; Ferrarese, C; Frattola, L; Piolti, R1
Casacchia, M; Cesana, B; Farolfi, A; Magni, G; Priore, P; Rossi, A; Stratta, P1
Csanalosi, I; Rickels, K; Schweizer, E1

Reviews

2 review(s) available for alpidem and Anxiety Neuroses

ArticleYear
Studies with alpidem in normal volunteers and anxious patients.
    Pharmacopsychiatry, 1990, Volume: 23 Suppl 3

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Humans; Imidazoles; Pyridines; Reference Values

1990
On the therapeutic action of alpidem in anxiety disorders: an overview of the European data.
    Pharmacopsychiatry, 1990, Volume: 23 Suppl 3

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Europe; Humans; Imidazoles; Pyridines

1990

Trials

7 trial(s) available for alpidem and Anxiety Neuroses

ArticleYear
Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.
    Neuropsychobiology, 1995, Volume: 31, Issue:2

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Attention; Automobile Driving; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Imidazoles; Lorazepam; Middle Aged; Naphthyridines; Ondansetron; Piperazines; Psychomotor Performance; Pyridines; Sulfur Compounds

1995
Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 165, Issue:1

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imidazoles; Male; Middle Aged; Neurologic Examination; Personality Assessment; Pyridines; Substance Withdrawal Syndrome; Treatment Outcome

1994
Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Pharmacopsychiatry, 1992, Volume: 25, Issue:4

    Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Galvanic Skin Response; Humans; Imidazoles; Lorazepam; Male; Memory; Middle Aged; Psychiatric Status Rating Scales; Pyridines; Reaction Time

1992
Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trial.
    Clinical neuropharmacology, 1992, Volume: 15, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Humans; Imidazoles; Male; Psychiatric Status Rating Scales; Psychomotor Performance; Pyridines

1992
Studies with alpidem in normal volunteers and anxious patients.
    Pharmacopsychiatry, 1990, Volume: 23 Suppl 3

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Humans; Imidazoles; Pyridines; Reference Values

1990
Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
    Clinical neuropharmacology, 1989, Volume: 12, Issue:1

    Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Psychomotor Performance; Pyridines; Random Allocation

1989
A double-blind, placebo-controlled study of alpidem, a novel anxiolytic of imidazopyridine structure, in chronically anxious patients.
    Acta psychiatrica Scandinavica, 1989, Volume: 80, Issue:2

    Topics: Adjustment Disorders; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Chronic Disease; Conversion Disorder; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Pyridines; Randomized Controlled Trials as Topic

1989

Other Studies

3 other study(ies) available for alpidem and Anxiety Neuroses

ArticleYear
[Fatal subfulminant hepatitis during treatment with alpidem (Ananxyl)].
    Gastroenterologie clinique et biologique, 1993, Volume: 17, Issue:11

    Topics: Aged; Anti-Anxiety Agents; Anxiety Disorders; Asthenia; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Humans; Imidazoles; Liver Function Tests; Pyridines

1993
Alpidem from pharmacology to clinic.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Humans; Imidazoles; Pyridines; Receptors, GABA-A

1992
Pilot study of alpidem, a new nonbenzodiazepine anxiolytic, in the treatment of generalized anxiety disorder.
    Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:1

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Humans; Imidazoles; Pilot Projects; Pyridines

1988